Carelizumab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Carelizumab, covering 2021-06-22 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC [Phase 3]